Rheumatoid Arthritis is an autoimmune disease that attacks the body’s own tissues, specifically the synovium, a thin membrane that lines the joints. As a result of the attack, fluid builds up in the joints, causing pain in the joints and inflammation that’s systemic.
Rheumatoid Arthritis (RA) is a chronic disease, meaning it can’t be cured. RA can lead to long-term joint damage, resulting in chronic pain, loss of function and disability. Most people with RA experience intermittent bouts of intense disease activity, called flares. In some people the disease is continuously active and gets worse over time. Others enjoy long periods of remission – no disease activity or symptoms at all. Evidence shows that early diagnosis and aggressive treatment to put the disease into remission is the best means of avoiding joint destruction, organ damage and disability.
Today, new treatments and advances in research are giving new hope to people affected by these diseases. The Rheumatoid Arthritis Cell Clinical Trials are being studied for their efficacy in improving the complications in patients with Rheumatoid Arthritis, through the use of stem cells. These procedures may help patients who don't respond to typical drug treatment.
To learn more about StemGenex clinical trials for Rheumatoid Arthritis simply fill out the form below and a StemGenex Patient Advocate will contact you shortly.
Fields marked with an asterisk (*) are required.
Question IDs
Object Type Map
Visibility Map
Active Map
Validator Map
Children Map
Parent Map
Question Options Map
Question Options
Question Option Activate Map